Target intelligence / Profile preview

Protein unc-119 homolog B (UNC119B)

Target
UNC119B
Molecular classification
Lipid binding chaperone/cofactor, Immunoglobulin-like β-sandwich fold protein, Protein trafficking factor (for myristoylated proteins), Other (not a receptor, ion channel, enzyme, transporter, or transcription factor)
01

Overview

Protein unc-119 homolog B (UNC119B) is a lipid-binding trafficking chaperone that accommodates and solubilizes N-myristoylated proteins, preventing their inappropriate localization and facilitating their directed transport within the cell. UNC119B contains an immunoglobulin-like β-sandwich fold which generates a hydrophobic pocket, allowing it to bind the myristoyl moiety of specific cargo proteins. Two classes of cargoes are distinguished by their affinity for UNC119B, and release is regulated by small GTPases such as ARL2 and ARL3. UNC119B exhibits nuanced specificity compared to its paralog UNC119A, including unique sequence features and alternative structural conformations which influence cargo protein binding and release. Its trafficking activity enables delivery of signaling proteins to the primary cilium and immunological synapse, making it essential for spatial regulation of membrane-associated proteins in various cell types, including photoreceptors, sensory neurons, and immune cells

Other names
UNC119BMGC5139POC7BPOC7 centriolar protein homolog BUnc-119 homolog BProtein unc-119 homolog B
02

Mechanism of action

Not applicable; UNC119B is not a direct drug target in current therapeutic strategies. Its function is protein-protein interaction based

03

Biological functions

Facilitates trafficking of N-myristoylated proteins between cellular membrane compartments by masking their hydrophobic moietyCargo sorting to primary cilium and immunological synapseCellular protein localizationRegulation of signaling hubs via localization of key signaling proteins
04

Disease associations

Nephronophthisis — trafficking of nephrocystin-3 to ciliaPotential indirect roles in immune function and signal transduction relevant to T-cell activationOther (roles emerging in ciliary function and diseases of trafficking)
05

Safety considerations

None established in current literature; therapeutic targeting challenges may relate to broad trafficking roles and potential for off-target effects in key cellular compartments if manipulated
06

Interacting drugs

None identified; no approved or experimental drugs directly target UNC119B as of current literature
07

Biomarkers

None reported; UNC119B is not used in clinical biomarker panels for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Protein unc-119 homolog B (UNC119B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein unc-119 homolog B (UNC119B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call